| Enhancing Survivorship Care Planning for Patients With Localized Prostate Cancer Using A Couple-focused Web-based Tailored Symptom Self-management Program (NCT04350788) | UNC Lineberger Comprehensive Cancer Center | 2017-08-03 |
| Post-Discharge Opioid Reduction Intervention for Open, Laparoscopic, and Endoscopic Surgery (NCT03536065) | Johns Hopkins University | 2017-08-01 |
| Correlation of Imaging Findings With Clinical Findings and Patient Outcomes in Prostate Cancer (NCT03122470) | Case Comprehensive Cancer Center | 2017-08-01 |
| Effect of Androgen Deprivation Therapy on Cardiovascular Function in Prostate Cancer (NCT03275181) | Kansas State University | 2017-08-01 |
| Culturally Tailored Decision Aid for Hispanic Patients Diagnosed With Prostate Cancer (NCT03157947) | Case Comprehensive Cancer Center | 2017-08-01 |
| Effect of Ramosetron on Heart Rate-corrected QT Interval During Robot-assisted Laparoscopic Prostatectomy With Steep Trendelenburg Position (NCT03232125) | Yonsei University | 2017-08-01 |
| Project HERO: Health Empowerment & Recovery Outcomes (NCT03345563) | Rutgers, The State University of New Jersey | 2017-07-31 |
| Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy (NCT03044197) | The University of Texas Medical Branch, Galveston | 2017-07-25 |
| International Registry for Men With Advanced Prostate Cancer (IRONMAN) (NCT03151629) | Prostate Cancer Clinical Trials Consortium | 2017-07-21 |
| Preliminary Evaluation of Uptake of [68Ga]P16-093 in Metastatic Prostate and Renal Cancer (NCT03073395) | Five Eleven Pharma, Inc. | 2017-07-21 |
| Decision Aids to Improve Knowledge in Patients With Prostate Cancer (NCT03182998) | Mayo Clinic | 2017-07-14 |
| Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Prostate Cancer (NCT03334500) | Abramson Cancer Center at Penn Medicine | 2017-07-14 |
| To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer Patients (NCT03017313) | Ipsen | 2017-07-13 |
| Effect of Mannitol on Optic Nerve Sheath Diameter in Patients Undergoing Robotic Prostatectomy (NCT03214055) | Asan Medical Center | 2017-07-12 |
| A Phase Ib Study of Intravenous Copper Loading With Oral Disulfiram in Metastatic, Castration Resistant Prostate Cancer (NCT02963051) | Daniel George, MD | 2017-07-11 |
| Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer (NCT03098836) | Daniel George, MD | 2017-07-10 |
| A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer (NCT03148795) | Pfizer | 2017-07-04 |
| Applications of Dual Energy CT in Patients With Osseous Metastases From Castrate-resistant Prostate Cancer (NCT03111914) | Duke University | 2017-07-03 |
| PREvention of VENous ThromboEmbolism Following Radical Prostatectomy (NCT03006562) | Johns Hopkins University | 2017-07-01 |
| Correlation Between SUV on 18F-DCFPyL PET/CT and Gleason Score in Prostate Cancer (NCT03001895) | Sir Mortimer B. Davis - Jewish General Hospital | 2017-07-01 |
| Point in Time of Radiotherapy for Patients With Biochemical Recurrent Prostate Carcinoma (NCT02181192) | University of Erlangen-Nürnberg Medical School | 2017-07-01 |
| 68Ga-PSMA PET/CT in Prostate Cancer (NCT03001869) | Sir Mortimer B. Davis - Jewish General Hospital | 2017-07-01 |
| Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy (NCT00737893) | Johns Hopkins University | 2017-07-01 |
| AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas (NCT03205176) | AstraZeneca | 2017-06-30 |
| Observational Prospective Study Describing the Global Patient Care and Follow-up of Prostate Cancer Patients Treated With Degarelix (NCT03193645) | Ferring Pharmaceuticals | 2017-06-27 |
| Phase IV Study to Evaluate Bone Mineral Density in No-bone Metastatic Prostate Cancer Treated With Degarelix (NCT03202381) | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 2017-06-26 |
| PSMA PET Imaging of Recurrent Prostate Cancer (NCT03204123) | Memorial Sloan Kettering Cancer Center | 2017-06-26 |
| A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients (NCT03035032) | Astellas Pharma Singapore Pte. Ltd. | 2017-06-23 |
| A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer (NCT03093272) | Dana-Farber Cancer Institute | 2017-06-23 |
| Neoadjuvant Hiltonol® (PolyICLC) for Prostate Cancer (NCT03262103) | Ashutosh Kumar Tewari | 2017-06-16 |
| Ketogenic Diet and Prostate Cancer Surveillance Pilot (NCT03194516) | University of Maryland, Baltimore | 2017-06-12 |
| Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC (NCT03093428) | Dana-Farber Cancer Institute | 2017-06-09 |
| Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer (NCT03081481) | Sophiris Bio Corp | 2017-06-07 |
| 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer (NCT03173924) | National Cancer Institute (NCI) | 2017-06-06 |
| Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors (NCT02538432) | University of Maryland, Baltimore | 2017-06-01 |
| The Value of PSMA-PET Compared With Multi-parametric MRI in the Detection Prostate Lesions (NCT03174054) | Assuta Medical Center | 2017-06-01 |
| Prostate Biopsies With Target Lesion on MRI (NCT04692207) | University Hospital, Montpellier | 2017-06-01 |
| Infectious Outcomes of Povidone-iodine Rectal Cleansing Plus Formalin Disinfection of Needle During Prostate Biopsy (NCT03879486) | Hospital de Transplante Doutor Euryclides de Jesus Zerbini | 2017-05-31 |
| PC 360 Survivorship (NCT03017456) | University Health Network, Toronto | 2017-05-29 |
| Multiparametric Ultrasound-Study for the Detection of Prostate Cancer (NCT03091231) | Martini-Klinik am UKE GmbH | 2017-05-15 |
| A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate Cancer (NCT03348527) | Lidds AB | 2017-05-12 |
| Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer (NCT03159676) | Mayo Clinic | 2017-05-12 |
| Immunotherapy Study of Evofosfamide in Combination With Ipilimumab (NCT03098160) | Threshold Pharmaceuticals | 2017-05-10 |
| Using PROMIS as Part of Routine Clinical Care for Racially Diverse Prostate and Bladder Cancer Patients (NCT03156244) | UNC Lineberger Comprehensive Cancer Center | 2017-05-08 |
| PSA TOOL for Prostate Cancer Screening Discussions (NCT03135444) | Case Comprehensive Cancer Center | 2017-05-02 |
| Genetic Biomarker Discovery for Metastatic Prostate Cancer (NCT03228810) | Mayo Clinic | 2017-05-02 |
| Effect of Enzalutamide Dose Reduction on Fatigue, Cognition, and Drug Trough Levels in Patients With Prostate Cancer (NCT03124615) | Macquarie University, Australia | 2017-05-01 |
| Effectiveness of Care in Certified Cancer Centres in Germany (NCT04334239) | Technische Universität Dresden | 2017-05-01 |
| Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer (NCT07184957) | NYU Langone Health | 2017-05-01 |
| The Efficacy and Safety of Composite Steep-pulse Treatment Apparatus Used in Prostate Cancer Focal Therapy (NCT03315585) | Second Military Medical University | 2017-04-27 |
| A Pilot Study of Prostate Cancer-specific Anxiety in Active Surveillance (NCT03227744) | NYU Langone Health | 2017-04-19 |
| A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer (NCT03085095) | Myovant Sciences GmbH | 2017-04-18 |
| PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer (NCT02933255) | National Cancer Institute (NCI) | 2017-04-18 |
| Physical Activities by Technology Help (PATH) (NCT03212079) | Johns Hopkins University | 2017-04-03 |
| Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate (NCT02944201) | Montefiore Medical Center | 2017-04-01 |
| ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents. (NCT02933801) | Swiss Cancer Institute | 2017-03-31 |
| Prospective Validation of Prostate Biomarkers for Repeat Biopsy (NCT03082274) | MDx Health | 2017-03-31 |
| RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours (NCT03199872) | RhoVac APS | 2017-03-30 |
| UNDISTORT Correction of Distortions in Diffusion MRI V1.0 (NCT03151512) | University College, London | 2017-03-29 |
| Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate Cancer (NCT02946008) | University of Michigan Rogel Cancer Center | 2017-03-27 |
| A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650) (NCT02985957) | Bristol-Myers Squibb | 2017-03-26 |
| Biobank for African American Prostate Cancer Research in Florida (NCT03232411) | H. Lee Moffitt Cancer Center and Research Institute | 2017-03-22 |
| Safety and Security Evaluation of Patients Submitted to Minimally Invasive Radical Prostatectomy (NCT03674996) | Barretos Cancer Hospital | 2017-03-22 |
| Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin (NCT03043989) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-03-21 |
| PSMA PET/CT for Assessment of Recurrent Prostate Cancer (NCT02899312) | British Columbia Cancer Agency | 2017-03-16 |
| Prostate Cancer Survey (NCT03128710) | University of Maryland, Baltimore | 2017-03-15 |
| VMAT for Dominant Intraprostatic Lesion (NCT03030625) | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | 2017-03-13 |
| CART-PSMA-TGFβRDN Cells for Castrate-Resistant Prostate Cancer (NCT03089203) | University of Pennsylvania | 2017-03-08 |
| Staying Strong and Healthy During Androgen Deprivation Therapy (ADT) for Men (NCT02969577) | University of Kansas Medical Center | 2017-03-07 |
| A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer (NCT03009981) | Alliance Foundation Trials, LLC. | 2017-03-06 |
| Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSA (NCT03187990) | Irene Burger | 2017-03-03 |
| Effects of Urinary Bladder Hypertrophy on Urge Urine Incontinence After Radical Prostatectomy (NCT03061760) | Collegium Medicum w Bydgoszczy | 2017-03-01 |
| Neoadjuvant Listeria or Daratumumab in Prostate Cancer (NCT03035357) | M.D. Anderson Cancer Center | 2017-03-01 |
| Less to Hold - A Comparison of Bladder Toxicities (Side Effects) in Patients Undergoing Prostate Radiotherapy Between Patients Treated With Empty Bladder and Those on a Drinking Protocol. (NCT03832803) | Lancashire Teaching Hospitals NHS Foundation Trust | 2017-03-01 |
| Fertility After Prostate Brachytherapy (NCT04278443) | East and North Hertfordshire NHS Trust | 2017-02-24 |
| A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy (NCT03043807) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-02-22 |
| Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer (NCT04060043) | CMX Research | 2017-02-21 |
| MiProstate - Information Hub for the Prostate Cancer Care Flow (NCT05239377) | Karolinska University Hospital | 2017-02-21 |
| Assessment of New Molecular Imaging Strategies for Prostate Cancer (NCT02813226) | Ontario Clinical Oncology Group (OCOG) | 2017-02-16 |
| Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer (NCT02923180) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-02-14 |
| Erectile Recovery After Robotic-Assisted Laparoscopic Prostatectomy (NCT03406169) | Brooke Army Medical Center | 2017-02-13 |
| Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer (NCT02995330) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-02-09 |
| PSMA Imaging of Localized Prostate Cancer (NCT03675451) | Weill Medical College of Cornell University | 2017-02-08 |
| A COMbined progRamme of Exercise and Dietary ADvice in mEn With Castrate Resistant Prostate Cancer (NCT03017417) | Sheffield Teaching Hospitals NHS Foundation Trust | 2017-02-08 |
| Trial to Investigate the Benefit of Elective Para-Aortic Radiotherapy (PART) for pN1 Prostate Cancer (NCT03079323) | Universitaire Ziekenhuizen KU Leuven | 2017-02-06 |
| Respiratory Measurement Using Infrared Camera and Respiratory Volume Monitor (ExSpiron 1Xi) for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia (NCT02993497) | Yonsei University | 2017-02-05 |
| The Safety and Pharmacokinetics of IMP4297 in Patients With Advanced Solid Tumors (NCT03507543) | Impact Therapeutics, Inc. | 2017-02-03 |
| Predictors of Normal Tissue Response From the Microenvironment in Radiotherapy for Prostate and Head-and-neck Cancer (NCT03294122) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2017-02-02 |
| PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer (NCT03232164) | University of Wisconsin, Madison | 2017-02-02 |
| Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancer (NCT03029533) | Daewoong Pharmaceutical Co. LTD. | 2017-02-01 |
| Intimacy and Mindfulness Post-Prostate Cancer Treatment (NCT03177707) | Vancouver Prostate Centre | 2017-01-24 |
| Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (NCT03030885) | Memorial Sloan Kettering Cancer Center | 2017-01-19 |
| Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC) (NCT02903160) | Icahn School of Medicine at Mount Sinai | 2017-01-13 |
| Evaluation of Post-operative Biochemical Recurrence in Patients Submitted to Radical Prostatectomy Under General Opioid-free Anesthesia Compared to Conventional General Anesthesia (NCT03212456) | Instituto do Cancer do Estado de São Paulo | 2017-01-12 |
| Advanced Prostate Imaging of Recurrent Cancer After Radiotherapy (NCT02793284) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2017-01-09 |
| Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following Radiotherapy (NCT03017794) | Mayo Clinic | 2017-01-04 |
| Effects of PEEP on Intracranial and Intraocular Pressure in Robot-assisted Laparoscopic Radical Prostatectomy (NCT03031613) | Gangnam Severance Hospital | 2017-01-01 |
| Quality of Life and Shared Decision Making in Prostate Cancer (NCT03948204) | Norwegian Institute of Public Health | 2017-01-01 |
| A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer (NCT03013712) | First Affiliated Hospital of Chengdu Medical College | 2017-01-01 |
| Repurposing Metformin as Anticancer Drug: in Advanced Prostate Cancer (NCT03137186) | Mansoura University | 2017-01-01 |